الملخص
خلفيّة: Australia introduced structured pathology reporting guidelines for non-melanoma skin cancer (NMSC) including cutaneous squamous cell carcinoma (cSCC) in 2023 to encourage accurate histological assessment and recording of well recognised adverse prognostic factors that inform prognosis and the need for additional treatment. Deaths from cutaneous squamous cell carcinoma (cSCC) are increasing. Identifying high-risk cSCC (HRcSCC) cases early is critical, and the pathologist has a central role to play.
To read more of this article please اضغط هنا.